New data reveal major geographic disparities and highlight the urgent need for global action on prevention, early detection, and equitable access to treatment.
For roughly one in five people worldwide, cancer will become part of their lifetime. Global Cancer Statistics, 2026 estimates that nearly 21 million people were diagnosed with cancer in 2024 and 9.8 million died from the disease.
About 1 in 9 men and 1 in 13 women are expected to die from cancer, while annual cases are projected to reach 34 million by 2050, a 67% increase driven solely by population growth and aging.
The report was produced by researchers at the American Cancer Society (ACS) and the International Agency for Research on Cancer (IARC), the cancer agency of the World Health Organization (WHO). The study was published in CA: A Cancer Journal for Clinicians, the flagship journal of ACS.
“Cancer is one of the greatest public health challenges of the 21st century and a major barrier to increasing life expectancy worldwide. Understanding the magnitude and geographic distributions of the disease is essential to guide effective and equitable prevention and control efforts,” said Dr. Hyuna Sung, senior principal scientist, cancer surveillance at the American Cancer Society and lead author of the report.
“While the scale of the cancer burden and the stark geographic disparities are sobering, they also point to a tremendous opportunity. Nearly half of all cancer deaths are estimated to be avoidable through potentially modifiable risk factors and an additional substantial proportion of cancer deaths can be prevented through early detection and timely treatment.”
Global data reveal stark inequalities
To build a worldwide picture of cancer, the researchers used 2024 estimates from GLOBOCAN, an IARC database covering cancer incidence and mortality for 34 cancer types of cancer across 186 countries. They compared national patterns by region and Human Development Index, then projected the burden through 2050 using demographic trends.
Where people live shapes cancer survival
Cancer incidence varied by approximately four- to fivefold across regions, with the highest rates recorded in Australia and New Zealand and the lowest in parts of Africa and South-Central Asia. Cancer mortality differed by about twofold, reaching its highest levels among men in Eastern Europe and women in Melanesia. Lung cancer remained the leading cancer worldwide for both diagnoses and deaths, largely because of tobacco use, accounting for nearly 2.6 million new cases and 1.9 million deaths in 2024.
Female breast cancer ranked second globally by incidence, with 2.4 million new cases and 694,000 deaths, and it remained the leading cancer among women for both diagnoses and mortality. Notably, women in Western Africa were twice as likely to die from breast cancer as women in Australia and New Zealand despite having only half the incidence rate, underscoring major inequalities in access to diagnosis and treatment.
Colorectal cancer ranked third in new diagnoses and second in cancer deaths, with more than 2 million cases and 918,000 deaths, while liver cancer caused 843,000 new cases and 732,000 deaths, making it the third leading cause of cancer mortality.
Prostate cancer was the second most frequently diagnosed cancer among men and the fourth leading cause of cancer death, with 1.5 million new cases and 420,000 deaths. Mortality was especially high in the Caribbean and Sub-Saharan Africa, where prostate cancer is often the leading cause of cancer death among men. Stomach cancer accounted for about 980,000 new cases and 642,000 deaths, ranking fifth for both incidence and mortality, with the highest rates in Eastern Asia.
Cervical cancer, although largely preventable through HPV vaccination and screening, remained the leading cause of cancer death among women in 26 countries, mainly in sub-Saharan Africa and parts of South and Central America. Pancreatic cancer caused 491,000 deaths, ranking sixth in mortality despite placing only 11th in incidence. Thyroid cancer, meanwhile, accounted for nearly 1 million new cases worldwide, making it the sixth most commonly diagnosed cancer.
Prevention could avert many deaths
“Every region faces different cancer challenges, so every country needs a unique plan to mitigate the growing burden of cancer. However, cancer prevention must be every country’s top priority,” said Dr. Ahmedin Jemal, senior vice president of surveillance & health equity science at the American Cancer Society and co-author of the study. “We must intensify efforts to help people quit tobacco use, avoid cancer-linked infections, abstain from alcohol, maintain a healthy weight, and get more daily exercise.”
Reference: “Global cancer statistics 2024: GLOBOCAN estimates of incidence and mortality worldwide for 34 cancers in 186 countries” by Hyuna Sung, Adalberto M. Filho, Mathieu Laversanne, Jacques Ferlay, Rebecca L. Siegel, Isabelle Soerjomataram, Ahmedin Jemal and Freddie Bray, 8 July 2026, CA: A Cancer Journal for Clinicians.
DOI: 10.3322/caac.70090
News – Curated by Amanda Scott, Alias Group Creative
Follow her on Bluesky
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Quantum-Enabled Regenerative Health: Reimagining Wellness, Precision Health and Longevity Medicine
Introduction Healthcare is approaching a frontier where the quantum portfolio could influence not only how disease is diagnosed and treated, but how health itself is measured, modeled, predicted and preserved. Quantum computing, quantum simulation, [...]
FDA Clears First-of-Its-Kind Nonmedication Treatment for PTSD
The FDA has cleared a system that uses brain activity data to personalize magnetic stimulation for PTSD, adding a new nonmedication treatment option. Every day in the United States, approximately 17.5 veterans die by suicide, [...]
FDA approves breakthrough drug to treat advanced pancreatic cancer
The Food and Drug Administration (FDA) approved on Wednesday a drug that could extend the survival of those with metastatic pancreatic cancer. The drug, called daraxonrasib, will be sold under the brand name Rasonque [...]
AI Decodes a Hidden DNA Signal Linked to Disease-Causing Mutations
Machine learning identifies the likely “initiator” and enables new predictions about DNA mutations that can cause disease. Every human cell depends on tens of thousands of genes being switched on at the right time [...]
Pope Leo Urges Global Response to Congo’s Deadliest Ebola Outbreak
Pope Leo called for international action to address the Ebola outbreak in the Democratic Republic of Congo. The epidemic has claimed over 2,500 lives and is the nation's largest recorded outbreak. The Pope emphasized [...]
Is there a summer COVID-19 surge this year? Yep, it’s ramping up again
Hantavirus. Ebola. West Nile. Measles. And, of course, cyclospora — that stomach parasite making people miserable across the country. Americans have plenty to worry about this summer. But remember COVID-19? It may not be [...]
Natural Compound in Broccoli Could Help Treat a Rare, Incurable Neurological Disease
Swinburne researchers have discovered how broccoli could help treat an extremely rare and incurable disease that affects only about 200 Australians. A naturally occurring compound in broccoli is being investigated as a possible treatment [...]
Antibody recycling, FcRn and the next generation of biologics
FcRn plays a central role in regulating the half-life of IgG antibodies and albumin, making it a critical target in both antibody engineering and autoimmune disease therapy. This article explores the biology of FcRn, [...]
Ebola kills 2,300 in three months with no vaccine available for Congo’s deadliest ever outbreak
It’s Congo’s 17th outbreak, with a toll that has eclipsed that of the country’s 2018-2020 outbreak when 2,299 deaths out of 3,481 cases were recorded. The latest data shows 101 new cases and 33 [...]
Beyond an Agency: How AI, Creativity and Commercialization Are Converging Into a New Growth Model
At a moment when AI is forcing a fundamental rethink of how work gets done, the life sciences industry is grappling with a deeper question: what role should human creativity play in an increasingly [...]
New $60 Blood Test Detects Lung Cancer Without Costly DNA Sequencing
A simple blood test that detects chemical changes in DNA identified more than 90% of stage 2-4 lung cancers in an early study, without relying on costly DNA sequencing. Researchers at Tel Aviv University and collaborating [...]
Reducing drug development failures with human-relevant models and AI
Professor Joseph C. Wu of Stanford University explains how stem cells, human-relevant models and AI are helping researchers predict which drug candidates are most likely to succeed before clinical trials. Researchers now have access [...]
Half of vaccines are binned – ‘fridge-free’ versions could change that
Vaccines that do not need to be kept cool in a fridge have been successfully trialed in patients for the first time, say UK scientists. Currently, most vaccines need to be refrigerated or frozen [...]
Mushroom Mystery: The Fungus That Makes People See Tiny Humans
A mushroom sold in markets and served in restaurants in Southwest China has an unusual warning attached to it: cook it thoroughly, or you may start seeing tiny people. For decades, people have reported [...]
Artificial intelligence used to design brand new viruses
Artificial Intelligence has been used to design brand new viruses that are fully functional and can replicate in the laboratory, say US researchers. It is the first time whole genomes have been successfully designed [...]
